Futura Medical Statistics
Total Valuation
Futura Medical has a market cap or net worth of 36.11 million. The enterprise value is 27.34 million.
| Market Cap | 36.11M |
| Enterprise Value | 27.34M |
Important Dates
The last earnings date was Monday, April 14, 2025.
| Earnings Date | Apr 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +5.38% |
| Shares Change (QoQ) | -4.20% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 257.27M |
Valuation Ratios
The trailing PE ratio is 22.31.
| PE Ratio | 22.31 |
| Forward PE | n/a |
| PS Ratio | 2.07 |
| PB Ratio | 3.22 |
| P/TBV Ratio | 3.22 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 73.68 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.06, with an EV/FCF ratio of -16.35.
| EV / Earnings | 16.89 |
| EV / Sales | 1.48 |
| EV / EBITDA | 15.06 |
| EV / EBIT | 16.53 |
| EV / FCF | -16.35 |
Financial Position
The company has a current ratio of 2.47
| Current Ratio | 2.47 |
| Quick Ratio | 2.10 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 17.91% and return on invested capital (ROIC) is 10.77%.
| Return on Equity (ROE) | 17.91% |
| Return on Assets (ROA) | 6.12% |
| Return on Invested Capital (ROIC) | 10.77% |
| Return on Capital Employed (ROCE) | 12.76% |
| Revenue Per Employee | 1.25M |
| Profits Per Employee | 115,625 |
| Employee Count | 14 |
| Asset Turnover | 1.10 |
| Inventory Turnover | 18.57 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -74.47% in the last 52 weeks. The beta is 1.14, so Futura Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.14 |
| 52-Week Price Change | -74.47% |
| 50-Day Moving Average | 0.14 |
| 200-Day Moving Average | 0.35 |
| Relative Strength Index (RSI) | 48.38 |
| Average Volume (20 Days) | 4,806 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Futura Medical had revenue of 17.43 million and earned 1.62 million in profits. Earnings per share was 0.01.
| Revenue | 17.43M |
| Gross Profit | 12.13M |
| Operating Income | 1.56M |
| Pretax Income | 1.62M |
| Net Income | 1.62M |
| EBITDA | 1.71M |
| EBIT | 1.56M |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
The company has 8.26 million in cash and n/a in debt, giving a net cash position of 8.26 million.
| Cash & Cash Equivalents | 8.26M |
| Total Debt | n/a |
| Net Cash | 8.26M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 11.22M |
| Book Value Per Share | 0.04 |
| Working Capital | 7.08M |
Cash Flow
In the last 12 months, operating cash flow was 490,094 and capital expenditures -2.16 million, giving a free cash flow of -1.67 million.
| Operating Cash Flow | 490,094 |
| Capital Expenditures | -2.16M |
| Free Cash Flow | -1.67M |
| FCF Per Share | n/a |
Margins
Gross margin is 69.58%, with operating and profit margins of 8.93% and 9.28%.
| Gross Margin | 69.58% |
| Operating Margin | 8.93% |
| Pretax Margin | 9.27% |
| Profit Margin | 9.28% |
| EBITDA Margin | 9.81% |
| EBIT Margin | 8.93% |
| FCF Margin | n/a |
Dividends & Yields
Futura Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.38% |
| Shareholder Yield | -5.38% |
| Earnings Yield | 4.48% |
| FCF Yield | -4.63% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Futura Medical has an Altman Z-Score of 9.37.
| Altman Z-Score | 9.37 |
| Piotroski F-Score | n/a |